Ichor Medical, J&J deal

Ichor and Johnson & Johnson’s Janssen Pharmaceuticals Inc. subsidiary will combine Janssen’s preclinical DNA-based HBV vaccine candidates and Ichor’s TriGrid electroporation technology for clinical a...